1-butyl-3-methylimidazolium nitrate: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 16211113 |
| SCHEMBL ID | 395911 |
| MeSH ID | M0513189 |
| Synonym |
|---|
| 179075-88-8 |
| 1-butyl-3-methylimidazolium nitrate |
| 1-butyl-3-methyl-1h-imidazol-3-ium nitrate |
| AKOS015898196 |
| WPHIMOZSRUCGGU-UHFFFAOYSA-N |
| SCHEMBL395911 |
| mfcd08457696 |
| 1-butyl-3-methyl-1h-imidazolium nitrate |
| DTXSID20583365 |
| [bmim]no3 |
| AC-9543 |
| 1-butyl-3-methylimidazolium nitrate, >=95.0% (hplc) |
| FT-0767959 |
| 1-butyl-3-methylimidazol-3-ium;nitrate |
| AS-31358 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (17.74) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||